Prenatal diagnosis or prenatal screening refers to testing for diseases or conditions in a fetus or embryo before it is born. Non-invasive prenatal testing (NIPT) test can detect birth defects such as neural tube defects, Down syndrome, chromosome abnormalities, genetic disorders and other conditions, such as spina bifida, cleft palate, Tay–Sachs disease, sickle cell anemia, thalassemia, cystic fibrosis, Muscular dystrophy, and fragile X syndrome. NIPT is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and Turner syndrome (monosomy X) along with fetal sex determination. Amniocentesis, chorionic villus sampling (CVS), maternal serum screening, and nuchal translucency (NT) scan have been the primary diagnostic and screening methods for chromosomal abnormalities. NIPT is an innovative way of screening pregnancies for fetal chromosomal aneuploidies by analyzing fetal cell-free DNA circulating in maternal blood.
The global noninvasive prenatal testing market report estimates the market size (Revenue USD million – 2014 to 2021) for market segmentation based on NIPT-specific test types (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verify, VisibiliT, etc.), and forecasts growth trends (CAGR% – 2017 to 2021).
The global noninvasive prenatal testing market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global noninvasive prenatal testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global noninvasive prenatal testing market and included in this report are Ariosa Diagnostics, Berry Genomics, BGI Diagnostics, Illumina, Inc., LifeCodexx AG, LabCorp, Natera, Inc., and Sequenom, Inc.